Vimarsana
Biggest News Aggregation in the World

Page 7 - Silverstein Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Silverstein Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Silverstein Foundation Today - Breaking & Trending Today

Gain Therapeutics Presents Positive Preclinical Data on its Small Molecule Lead Compound in GBA1 Parkinson's Disease at XXVII IAPRD World Congress - Vimarsana News

Gain Therapeutics Presents Positive Preclinical Data on its Small Molecule Lead Compound in GBA1 Parkinson's Disease at XXVII IAPRD World Congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Gain Therapeutics Outlines Key Objectives for - Vimarsana News

Gain Therapeutics Outlines Key Objectives for

BETHESDA, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming...

Gain Therapeutics Progresses Krabbe Disease Program and - Vimarsana News

Gain Therapeutics Progresses Krabbe Disease Program and

Data Show Statistically Significant Increases in GALC Enzyme and Depletion of Toxic Substrate Psychosine...

Q&A: How DNA detective work is helping crack complex diseases - Vimarsana News

Q&A: How DNA detective work is helping crack complex diseases

Q&A: How DNA detective work is helping crack complex diseases 6 May, 2021 01:30 AM 6 minutes to read Recent breakthroughs in genetics have transformed our understanding of many complex diseases. Image / 123RF The human genetic code is mind-bogglingly complex - but it's a field of science Professor Justin O'Sullivan feels at home in. The deputy director of the University of Auckland's Liggins Institute, and a fellow of the Office of the Prime Minister's Chief Science Advisor, will be giving his inaugural professorial lecture tomorrow afternoon about genetics, complex diseases and the...

Bethesda's Gain Therapeutics Presents New GBA1 Parkinson's Disease Program Pre-clinical Data · BioBuzz - Vimarsana News

Bethesda's Gain Therapeutics Presents New GBA1 Parkinson's Disease Program Pre-clinical Data · BioBuzz

Compounds reverse the neurodegenerative process observed in a Parkinson’s disease in vivo model Compounds are novel allosteric regulators that bind, stabilize and restore activity of mutated GCase Compounds decrease both phosphorylated and aggregated α -synuclein levels in vitro and in vivo BETHESDA, Md., May 03, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by using super-computational methods to target allosteric binding sites and guide enzymes back to their proper shape, today announced new pr...

Source: biobuzz.io